0001415889-24-017160.txt : 20240617 0001415889-24-017160.hdr.sgml : 20240617 20240617161249 ACCESSION NUMBER: 0001415889-24-017160 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240613 FILED AS OF DATE: 20240617 DATE AS OF CHANGE: 20240617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shannon James Samuel CENTRAL INDEX KEY: 0001485417 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 241048348 MAIL ADDRESS: STREET 1: 28903 NORTH AVENUE PAINE CITY: VALENCIA STATE: CA ZIP: 91355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-06172024_080645.xml X0508 4 2024-06-13 0001840233 Xilio Therapeutics, Inc. XLO 0001485417 Shannon James Samuel 828 WINTER STREET SUITE 300 WALTHAM MA 02478 true false false false 0 Stock Option (right to buy) 1.05 2024-06-13 4 A 0 50000 0 A 2034-06-12 Common Stock 50000 50000 D The option was granted on June 13, 2024 and will vest in three equal installments on June 13, 2025, June 13, 2026 and June 13, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. /s/ Julia Walcott, Attorney-in-Fact 2024-06-17